[
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Laps the Stock Market: Here's Why",
    "summary": "Gilead Sciences (GILD) reached $112.69 at the closing of the latest trading day, reflecting a +1.93% change compared to its last close.",
    "url": "https://finnhub.io/api/news?id=3353181c040f0dac9b585deb2fb9cd6c5d2fb942cd5535e49d5d383f40a466cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759528802,
      "headline": "Gilead Sciences (GILD) Laps the Stock Market: Here's Why",
      "id": 136980946,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences (GILD) reached $112.69 at the closing of the latest trading day, reflecting a +1.93% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=3353181c040f0dac9b585deb2fb9cd6c5d2fb942cd5535e49d5d383f40a466cf"
    }
  },
  {
    "ts": null,
    "headline": "RBC Capital Maintains a Hold Rating on Gilead Sciences (GILD)",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best medical stocks to buy now. RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences, Inc. (NASDAQ:GILD) on September 29 and set a price target of $98.00. Gilead Sciences, Inc. (NASDAQ:GILD) reported a 2% growth in its total revenues for fiscal Q2 2025 to $7.1 [因",
    "url": "https://finnhub.io/api/news?id=a578c42d0bad8700bdea93dbbd5183d87c4bfdaa2e889ef3e76d69149f3b2a75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759487280,
      "headline": "RBC Capital Maintains a Hold Rating on Gilead Sciences (GILD)",
      "id": 136963253,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best medical stocks to buy now. RBC Capital analyst Brian Abrahams maintained a Hold rating on Gilead Sciences, Inc. (NASDAQ:GILD) on September 29 and set a price target of $98.00. Gilead Sciences, Inc. (NASDAQ:GILD) reported a 2% growth in its total revenues for fiscal Q2 2025 to $7.1 [因",
      "url": "https://finnhub.io/api/news?id=a578c42d0bad8700bdea93dbbd5183d87c4bfdaa2e889ef3e76d69149f3b2a75"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Foundation Commits Over $6.5M in New Grant Funding to Support STEM Education Pathways",
    "summary": "Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued stocks to buy and hold for 5 years. On September 25, Gilead Sciences announced that its Gilead Foundation has committed more than $6.5 million in new grant funding to strengthen Science, Technology, Engineering, and Math/STEM education pathways. The funding is part of an ongoing commitment [因",
    "url": "https://finnhub.io/api/news?id=618c3a6ec8863852ef0787fb85ac58df125a1f6f03de400f9105053f70631adc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759483992,
      "headline": "Gilead Foundation Commits Over $6.5M in New Grant Funding to Support STEM Education Pathways",
      "id": 136963254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences Inc. (NASDAQ:GILD) is one of the most undervalued stocks to buy and hold for 5 years. On September 25, Gilead Sciences announced that its Gilead Foundation has committed more than $6.5 million in new grant funding to strengthen Science, Technology, Engineering, and Math/STEM education pathways. The funding is part of an ongoing commitment [因",
      "url": "https://finnhub.io/api/news?id=618c3a6ec8863852ef0787fb85ac58df125a1f6f03de400f9105053f70631adc"
    }
  },
  {
    "ts": null,
    "headline": "3 Way-Too-Early Predictions For 2026",
    "summary": "Markets continue to advance despite continuing concerns around valuations, inflation, and the deteriorating jobs market. Read what investors need to know.",
    "url": "https://finnhub.io/api/news?id=2dd033855c21ace7dab4046d42fb6b4feb0d6bed732f97599bc4aa7fff222f45",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759479844,
      "headline": "3 Way-Too-Early Predictions For 2026",
      "id": 136963880,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2201849225/image_2201849225.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Markets continue to advance despite continuing concerns around valuations, inflation, and the deteriorating jobs market. Read what investors need to know.",
      "url": "https://finnhub.io/api/news?id=2dd033855c21ace7dab4046d42fb6b4feb0d6bed732f97599bc4aa7fff222f45"
    }
  }
]